Sjolin K E, Nyholm K, Trautner K
Acta Pathol Microbiol Scand A. 1976 Sep;84(5):361-74. doi: 10.1111/j.1699-0463.1976.tb00129.x.
Transitional cell tumours of the bladder from a total of 228 patients were histologically classified as papillomas, papillomatous carcinomas and non-papillomatous carcinomas. Each group was subdivided into four grades of dysplasia. Papillomas and papillomatous carcinomas occurred in younger patients at a higher rate than non-papillomatous carcinomas. The 5-year-survival of patients with papillomas and carcinomas was 70 per cent and 26 per cent, respectively. Among patients with papillomas with dysplasia grades 1 and 2 the survival rate was almost identical. In the group of patients with papilloma thrombo-embolic diseases were the most common cause of death. Carcinoma of the bladder developed in about 30 per cent of the patients in this group. Recurrence of the papilloma only rarely changed the grade of dysplasia. If the recurrence was in the form of a carcinoma, an increase in the grade of dysplasia was common. The survival was more favourable among patients with carcinoma dysplasia grade 2 than among those with dysplasia grade 3. The rate of survival was higher in the group of patients with papillomatous carcinoma than among patients with non-papillomatous carcinomas. Among the decreased patients with primary carcinomas, 77 per cent died with carcinoma of the bladder. To a certain degree, the grade of tumour cell dysplasia seems to be an expression of the malignancy of the tumours. The duration of the disease and the appearance of tumours (papillomatous, non-papillomatous) may have relation to the patients' "defence" system. At autopsy, the papillomatous and non-papillomatous carcinomas were found to be similarly disseminated regardless of the difference in survival rate.
对总共228例患者的膀胱移行细胞肿瘤进行组织学分类,分为乳头状瘤、乳头状癌和非乳头状癌。每组再细分为四级发育异常。乳头状瘤和乳头状癌在较年轻患者中的发生率高于非乳头状癌。乳头状瘤和癌患者的5年生存率分别为70%和26%。在发育异常1级和2级的乳头状瘤患者中,生存率几乎相同。在乳头状瘤患者组中,血栓栓塞性疾病是最常见的死亡原因。该组约30%的患者发生了膀胱癌。乳头状瘤的复发很少改变发育异常的级别。如果复发为癌的形式,则发育异常级别增加很常见。发育异常2级的癌患者的生存率高于发育异常3级的患者。乳头状癌患者组的生存率高于非乳头状癌患者。在原发性癌患者中,77%死于膀胱癌。在一定程度上,肿瘤细胞发育异常的级别似乎是肿瘤恶性程度的一种表现。疾病持续时间和肿瘤外观(乳头状、非乳头状)可能与患者的“防御”系统有关。尸检时发现,无论生存率有何差异,乳头状癌和非乳头状癌的播散情况相似。